Evan Cromwell (President & CEO, Protein Fluidics, Inc.) will discuss a novel method of automated time-course sampling of supernatants from 3D cell models coupled with highly sensitive luminescence-based assays for important metabolites such as lactate and glutamate. He will present the use of this system for profiling metabolism response of PD tumoroids to different treatments and its use in disease modeling.
Thursday Sep 9, 2021
For conference agenda check out the link here.
During the session learn about Pu·MA System applications for your drug discovery assays, either at secondary screening stage
or with research in studying physiological responses in organoids, spheroids and tumoroids with a focus on organoid metabolite analysis.
Protein Fluidics, Inc.
875 Cowan Road, Suite B,
Burlingame, CA 94010
+1 650 529 5080